Patients with resectable melanoma who received T-VEC prior to surgery achieved better 5-year OS than those who underwent surgery alone.
2023
A medication used for heart conditions improves the efficacy of current treatments for melanoma in mouse models
A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d’Alacant, Valencian Community) and IRB Barcelona (Barcelona, Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.
Life insurers can charge more or decline cover based on your genetic test results. New laws must change this
Genetic tests can provide life-saving information. They can help diagnose disease, enable access to preventive care, prompt early screening and treatment, and guide patients’ therapeutic options.
Skin cancer: Which EU countries have the highest melanoma incidence and mortality rates?
The EU cancer body places melanoma as the sixth most common cancer for both men and women. Meanwhile, some “influencers” are advising against sunscreen.